Skip to content
← Back to this collection

PUBLICATIONS · 28380315

Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2017 Apr 10
First author
Scott BL

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Scott BL
      type
      Author
    2. name
      Pasquini MC
      type
      Author
    3. name
      Logan BR
      type
      Author
    4. name
      Wu J
      type
      Author
    5. name
      Devine SM
      type
      Author
    6. name
      Porter DL
      type
      Author
    7. name
      Maziarz RT
      type
      Author
    8. name
      Warlick ED
      type
      Author
    9. name
      Fernandez HF
      type
      Author
    10. name
      Alyea EP
      type
      Author
    11. name
      Hamadani M
      type
      Author
    12. name
      Bashey A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Scott BL
      type
      Author
    2. name
      Pasquini MC
      type
      Author
    3. name
      Logan BR
      type
      Author
    4. name
      Wu J
      type
      Author
    5. name
      Devine SM
      type
      Author
    6. name
      Porter DL
      type
      Author
    7. name
      Maziarz RT
      type
      Author
    8. name
      Warlick ED
      type
      Author
    9. name
      Fernandez HF
      type
      Author
    10. name
      Alyea EP
      type
      Author
    11. name
      Hamadani M
      type
      Author
    12. name
      Bashey A
      type
      Author
    bibliography ids
    1. nci-bib-24ba67c102fb917b8a34065c
    book metadata
    content sha256
    1a5619d8f3438402121ff756041cea12f145437052cd14bacda86e9d1c238f6e
    document type
    citation
    dois
    1. 10.1200/JCO.2016.70.7091
    electronic publication date
    display
    2017 Feb 13
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28380315
    immutable id
    pubmed:28380315@1a5619d8f3438402121ff756041cea12f145437052cd14bacda86e9d1c238f6e
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    11
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1154-1161
    volume
    35
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28380315
      provenance
      batch id
      1c173f0e18be0c6d461b
      provider
      NCBI PubMed ESummary
      record sha256
      097bb0d330b0d0edf1d87df2a54fb261c761fdbec73487962df11f53e60a83ce
      response sha256
      27a6f8bb5d49a8d376b07e1b1768913c558986bf73de92cdd65c8f05a5fa1e61
      retrieved at
      2026-09-09T23:47:25.975513+00:00
      publication date
      display
      2017 Apr 10
      precision
      day
      year
      2017
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Randomized Controlled Trial
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28380315/
      title
      Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes.

      Preserved source evidence · Not medical advice